HIMS
Hims & Hers Health, Inc.
There isn't enough reported data to score HIMS yet.
ISPC
iSpecimen Inc.
There isn't enough reported data to score ISPC yet.
HIMS Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Stable | |
| Strong |
HIMS's revenue and balance sheet are currently strong, and its cash flow is stable, but its profitability is weak.
ISPC Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Unavailable | |
| Unavailable |
ISPC's revenue and profitability are currently under pressure. There isn't enough data to rate its cash flow and balance sheet.
HIMS PE Valuation
HIMS has no meaningful PE right now: it lost money over the past year.
ISPC PE Valuation
ISPC has no meaningful PE right now: it lost money over the past year.
HIMS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Turning to a loss | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect HIMS's revenue to grow, but its earnings to decline. However, they disagree widely on these estimates.
ISPC Forward outlook
There aren't enough analyst estimates for ISPC to show an outlook.
HIMS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.83 | -257% |
| Q2 2026 | -$0.63 | -180% |
| Q1 2026 | -$0.09 | -113% |
| Q4 2025 | $0.51 | -3.8% |
| Q3 2025 | $0.53 | +20% |
| Q2 2025 | $0.79 | +888% |
| Q1 2025 | $0.68 | +$0.69 |
| Q4 2024 | $0.53 | +$0.64 |
HIMS has swung to a loss: it lost $0.83 per share over the past year, after a profit the year before.
ISPC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$53.64 | +$674.36 |
| Q1 2026 | -$69.46 | +$793.74 |
| Q4 2025 | -$91.20 | +$999.60 |
| Q3 2025 | -$663.20 | +$116.80 |
| Q2 2025 | -$728.00 | +$152.00 |
| Q1 2025 | -$863.20 | +$176.80 |
| Q4 2024 | -$1,090.80 | -$106.80 |
| Q3 2024 | -$780.00 | +$108.00 |
ISPC has the edge over HIMS on earnings, with more consistent year-over-year improvement.
HIMS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $890.4M | +49% |
| Q2 2026 | $753.2M | +38% |
| Q1 2026 | $608.1M | +3.8% |
| Q4 2025 | $617.8M | +28% |
| Q3 2025 | $599M | +49% |
| Q2 2025 | $544.8M | +73% |
| Q1 2025 | $586M | +111% |
| Q4 2024 | $481.1M | +95% |
HIMS has the edge over ISPC on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -7.4% | -9.4 points |
| Q2 2026 | -13% | -18 points |
| Q1 2026 | -13% | -23 points |
| Q4 2025 | 1.5% | -2.4 points |
| Q3 2025 | 2% | -3.6 points |
| Q2 2025 | 4.9% | +1.4 points |
| Q1 2025 | 9.9% | +6.3 points |
| Q4 2024 | 3.9% | +4 points |
HIMS has the edge over ISPC on profitability, with a higher operating margin.
ISPC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $151.9K | -79% |
| Q1 2026 | $156K | -85% |
| Q4 2025 | $51.8K | -96% |
| Q3 2025 | $106.6K | -96% |
| Q2 2025 | $713.1K | -75% |
| Q1 2025 | $1.1M | -54% |
| Q4 2024 | $1.5M | -43% |
| Q3 2024 | $2.7M | -4.2% |
ISPC's revenue has slid since its 2022 peak: $151,940 last quarter, down 79% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -897% | -642 points |
| Q1 2026 | -1627% | -1472 points |
| Q4 2025 | -5193% | -4797 points |
| Q3 2025 | -2655% | -2591 points |
| Q2 2025 | -255% | -179 points |
| Q1 2025 | -155% | -24 points |
| Q4 2024 | -396% | -284 points |
| Q3 2024 | -64% | +15 points |
ISPC's operating margin was −897% last quarter, down 642 points from the same quarter a year ago.
HIMS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $26M | -67% |
| Q2 2026 | -$68.2M | +$1.3M |
| Q1 2026 | $53.1M | +5.9% |
| Q3 2025 | $79.3M | -7% |
| Q2 2025 | -$69.5M | -230% |
| Q1 2025 | $50.1M | +94% |
| Q3 2024 | $85.3M | +238% |
| Q2 2024 | $53.6M | +219% |
ISPC has the stronger cash trend. Its trailing FCF is down 40% versus its history, compared with HIMS at down 84%.
ISPC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$916.9K | +$2.7M |
| Q3 2025 | -$2M | -$941.6K |
| Q4 2024 | -$3.6M | -1137% |
| Q3 2024 | -$1.1M | +$545.5K |
| Q2 2024 | -$1.5M | +$159.8K |
| Q1 2024 | -$2.1M | +$752.1K |
| Q1 2023 | -$2.8M | -$1.5M |
ISPC has burned cash in almost every quarter: −$10M over the past year, against −$4M the year before.
HIMS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.9% | +2.1M shares |
| 1 year | -6% | -14.9M shares |
| 3 years | +11% | +23.7M shares |
| 5 years | +17% | +33.8M shares |
HIMS has the edge over ISPC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2025 | $80.5M |
| Q3 2025 | $9.5M |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | $5M |
| Q3 2024 | $30M |
| Q2 2024 | $19.9M |
| Q1 2024 | $28.1M |
ISPC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +308% | +1.1M shares |
| 1 year | +2301% | +1.3M shares |
| 3 years | +12322% | +1.4M shares |
ISPC has 1M diluted shares, up 2301% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | $52,500 |
HIMS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | -5.9x | Net Cash |
| Q4 2025 | -1.4x | Net Cash |
| Q3 2025 | -2.2x | Net Cash |
| Q2 2025 | -7.3x | Net Cash |
| Q1 2025 | -2.1x | Net Cash |
| Q4 2024 | -2.8x | Net Cash |
| Q3 2024 | -2.9x | Net Cash |
| Q2 2024 | -5.5x | Net Cash |
HIMS has more cash than debt.
ISPC Net Leverage
ISPC's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
HIMS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 36.0 | Neutral |
| Stochastic | 23.0 | Neutral |
HIMS's weekly RSI is 36 (neutral) and its Stochastic is 23 (neutral).
ISPC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 25.7 | Oversold |
| Stochastic | 3.4 | Oversold |
ISPC's weekly RSI is 26 (oversold) and its Stochastic is 3 (oversold).
HIMS PE vs Healthcare Sector
| Metric | HIMS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
HIMS has no meaningful PE right now: it lost money over the past year.
ISPC PE vs Healthcare Sector
ISPC has no meaningful PE right now: it lost money over the past year.
HIMS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.3 | 28% below |
| 20 week MA | $29.2 | 32% below |
| 50 week MA | $27.7 | 29% below |
| 100 week MA | $35.9 | 45% below |
| 200 week MA | $24.4 | 19% below |
HIMS is in a downtrend: it's below all five of its weekly moving averages, and 19% below its 200-week average.
ISPC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.94 | 26% below |
| 20 week MA | $1.53 | 54% below |
| 50 week MA | $6.03 | 88% below |
| 100 week MA | $29.8 | 98% below |
| 200 week MA | $303.4 | 100% below |
ISPC is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
HIMS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.89 | $15.0 | +51% |
| 2021 | $15.0 | $6.65 | -56% |
| 2022 | $6.65 | $6.43 | -3.3% |
| 2023 | $6.43 | $8.90 | +38% |
| 2024 | $8.90 | $26.6 | +198% |
| 2025 | $26.6 | $34.3 | +29% |
| 2026 YTD | $34.3 | $19.7 | -42% |
HIMS has the edge over ISPC on returns for 2026, with the stronger performance.
ISPC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $5,992.0 | $9,288.0 | +55% |
| 2022 | $9,288.0 | $1,056.0 | -89% |
| 2023 | $1,056.0 | $400.4 | -62% |
| 2024 | $400.4 | $112.4 | -72% |
| 2025 | $112.4 | $15.3 | -86% |
| 2026 YTD | $15.3 | $0.70 | -95% |
ISPC has finished four years in a row lower, and it's down 95% so far in 2026.